News & Events about Inari Medical Inc.
Inari Medical, Inc. (NASDAQ:NARI Get Rating) CEO Andrew Hykes sold 9,000 shares of the firms stock in a transaction that occurred on Friday, January 20th. The stock was sold at an average price of $61.90, for a total transaction of $557,100.00. Following the transaction, the chief ...
Inari Medical, Inc. (NASDAQ:NARI Get Rating) Director William Hoffman sold 55,000 shares of Inari Medical stock in a transaction dated Tuesday, January 17th. The shares were sold at an average price of $66.90, for a total transaction of $3,679,500.00. Following the sale, the director now ...
IRVINE, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (Inari) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that the first patient has been enrolled in DEFIANCE, a ...
IRVINE, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (Inari), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced preliminary unaudited fourth quarter and full year 2022 revenue...
Inari Medical, Inc. (NASDAQ:NARI Get Rating) CEO William Hoffman sold 55,000 shares of the firms stock in a transaction that occurred on Tuesday, November 15th. The stock was sold at an average price of $81.67, for a total transaction of $4,491,850.00. Following the sale, the chief executive officer...